Lobo, Juliet G.
HRN: 20-89-80 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/06/2024
CEFUROXIME 500MG (TAB)
04/06/2024
04/12/2024
PO
500mg
BID
NSVD Wbc Of 19
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes